Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01057667
Show Display Options
Rank Status Study
1 Completed A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4
Condition: Hepatitis C, Chronic
Interventions: Drug: RO5024048;   Drug: Ribavirin [Copegus];   Drug: peginterferon alfa-2a [Pegasys]

Study has passed its completion date and status has not been verified in more than two years.